Equities

Alliance Pharma PLC

APH:LSE

Alliance Pharma PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)33.75
  • Today's Change-1.20 / -3.43%
  • Shares traded1.12m
  • 1 Year change-51.65%
  • Beta0.8418
Data delayed at least 20 minutes, as of May 13 2024 14:19 BST.
More ▼

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of GBP
(except for per share items)
Fiscal data as of Dec 31 2022202220212020
REVENUE AND GROSS PROFIT
Total revenue167163130
OPERATING EXPENSES
Cost of revenue total665447
Selling, general and admin. expenses, total646246
Depreciation/amortization9.208.537.16
Unusual expense(income)188.9913
Other operating expenses, total07.90--
Total operating expense157142113
Operating income112216
Other, net------
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes5.211813
Provision for income taxes4.27114.99
Net income after taxes0.947.328.03
Minority interest------
Net income before extra. Items0.947.328.03
Total extraordinary items------
Net income0.947.328.03
Inc.avail. to common excl. extra. Items0.947.328.03
Inc.avail. to common incl. extra. Items0.947.328.03
EPS RECONCILIATION
Basic/primary weighted average shares539535531
Basic/primary eps excl. extra items0.000.010.02
Basic/primary eps incl. extra items0.000.010.02
Dilution adjustment------
Diluted weighted average shares545542537
Diluted eps excl. extra items0.000.010.01
Diluted eps incl. extra items0.000.010.01
COMMON STOCK DIVIDENDS
DPS - common stock primary issue0.020.020.02
Gross dividend - common stock9.596.095.75
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental5.433.652.66
SUPPLEMENTAL INCOME
Depreciation, supplemental1.561.581.75
Total special items188.9914
NORMALISED INCOME
Normalized income before taxes232727
Effect of special items on income taxes(2.96)2.81(1.38)
Income tax excluding impact of special items1.31143.61
Normalized income after tax221423
Normalized income avail. to common221423
Basic normalized EPS0.040.030.04
Diluted normalized EPS0.040.020.04
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.